What Does Wall Street Think About UnitedHealth Group (UNH)?

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best medical stocks to buy now. In a report released on September 18, Ryan Langston from TD Cowen maintained a Hold rating on UnitedHealth Group Incorporated (NYSE:UNH) and set a price target of $275.00.

However, UBS reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on September 19 with a $378 price target. Lance Wilkes from Bernstein also expressed bullish sentiments for the stock on September 17, assigning UnitedHealth Group Incorporated (NYSE:UNH) a Buy rating with a $379 price target.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.